Medical Properties Trust (MPT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
19 Feb, 2026Executive summary
Q2 2025 delivered strong operational and financial performance, with new tenants ramping up rent payments and stabilized assets contributing steady cash flow; net loss was $98.4 million ($0.16 per share), a significant improvement from Q2 2024, mainly due to lower impairment charges and fair value adjustments.
Normalized FFO for Q2 2025 was $81.4 million ($0.14 per share), down 42% year-over-year, primarily due to lower revenues from asset sales and higher interest expense from refinancing.
Portfolio at June 30, 2025, included 392 properties and 39,000 licensed beds across nine countries, with total assets of $15.2 billion.
U.S. healthcare policy changes, including Medicaid funding and ACA work requirements, are expected to drive demand for innovative capital solutions.
Portfolio diversification across geographies and operators continues to support resilience and growth.
Financial highlights
Normalized FFO reported at $0.14 per share for Q2 2025, fully reflecting incremental interest from $2.5B in refinanced debt.
Net impairments and fair market value adjustments totaled approximately $111 million, mainly related to asset sales and bankruptcy transactions.
Q2 2025 total revenues were $240.4 million, down 10% year-over-year, mainly from lost rent due to property sales and the absence of Steward and Prospect rent.
Cash rent from new operators increased from $3.4M in Q1 to $11M in Q2, expected to reach $17M in Q3.
Interest expense increased to $129.7 million in Q2 2025 from $101.4 million in Q2 2024, driven by recent refinancing activities.
Outlook and guidance
Management expects annualized pro rata cash rent to exceed $1 billion by Q4 2026, with new operators expected to reach $160M annualized rent by October 2026.
Further increases in cash rents anticipated to positively impact bottom line as interest expense stabilizes.
No material new real estate investments are anticipated in the near term; focus remains on liquidity, re-tenanting, and asset sales.
Liquidity at August 5, 2025, was $1.2 billion, with no debt maturities due in the next twelve months.
Latest events from Medical Properties Trust
- EBITDARM coverage up to 2.6x; Q4 NFFO $0.18/share; $1B+ cash rent targeted for 2026.MPT
Q4 202519 Feb 2026 - Q3 2025 net loss narrowed, revenues rose 5%, and $150M buyback announced.MPT
Q3 202519 Feb 2026 - Q1 2025 delivered a net loss, strong liquidity, and stable rent collections amid restructuring.MPT
Q1 202519 Feb 2026 - Q2 net loss of $320.6M driven by Steward impairments, but $2.5B+ liquidity generated YTD.MPT
Q2 20242 Feb 2026 - Q3 loss of $801M, major asset sales, and re-tenanting set stage for $1B+ cash rent by 2026.MPT
Q3 202415 Jan 2026 - $5.5B in asset sales and debt refinancing strengthen liquidity despite a $4.02/share loss.MPT
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay-for-performance, and ESG progress.MPT
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay up for vote at annual meeting.MPT
Proxy Filing1 Dec 2025 - Executive pay is now tightly linked to performance, with reduced CEO compensation and new hurdles.MPT
Proxy Filing1 Dec 2025